Genetics Flashcards
What phase of cell cycle do chromosomes condense enough for karyotyping
metaphase
Haploinsufficiency
Reduction by about half in amount of protein usually due to whole gene deletion or frameshift mutation
Silent mutation
changes that don’t affect the A.A produced by the codon
Missense mutation
Change that affects the A.A produced by the codon
Nonsense mutation
Change that results in a stop codon
Frameshift mutation
Alters the reading frame, may lead to entirely different protein or a stop codon
Locus
The location of a gene on a chromosome
Allele
an Alternative variant of a particular gene
Polymorphism
where there are at least 2 or more relatively common alleles of a gene in a the population
Penetrance
on/off binary concept
Expressed or not expressed
Incomplete penetrance: may be age dependent like in huntington’s
Expressivity
Variability of clinical features/phenotype in people with the same genotype
Aneuploidy
an abnormal number of chromosomes
47 XXY condition and presentation
Klinefelter Syn
- Primary hypogonadism
- Low testosterone
- Infertility, incomplete virlisation, gynecomastia
- tall stature
- mild learning difficulty, shy, emotionally immature
45 X condition and presentation
Turner Syn
- Short stature, shield chest
- Webbed neck
- Infertility, ovarian dysgenesis
- Bicuspid Aortic valve, CoA
Inheritance of myotonic dystrophy
Triplet repeat disorder
-Maternal
Inheritance of huntington’s
Triplet repeat disorder
-Paternal
Inheritance of Spinocerebellar ataxia
Triplet repeat disorder
-Gender of transmitting parent can modify symptoms in child
Anticipation
The observation that a particular phenotype seems to be increasing in severity in subsequent generations
CpG islands
on promoter regions of genes and is the mechanism of regulating gene transcription
ncRNA
Non coding RNA
-Does not code for protein, but mediates gene regulation processes
What is gene expression influenced by
conformation of chromatin
methylation of DNA
Availability of transcription factors
Inheritance of Prader-Willi
Loss of paternally active 15q gene copy
- Paternal imprinting
- Paternal microdeletion
- Maternal UPD15
Inheritance of Angelman Syndrome
Loss of maternallly active 15q gene copy
- Maternal imprinting
- Maternal microdeletion
- Paternal UPD15
- UBE3A mutaton
RB1 -Condition and inheritance
AD
Retinoblastoma
Other features:
-melanoma
Osteosarcoma
Soft tissue cancers
Most familial cancers are due to germ line mutations in tumor suppressor genes rather than proto-onogenes except:
RET gene mutation - MEN 2
MENIN gene
MEN 1
AD inheritance
Features of MEN 1
Parathyroid adenoma
Pituitary adenoma
Pancreatic islet cell/GI adenoma
RET gene
MEN2
AD inheritance
MEN2a features
Medullary thyroid cancer
Phaochromocytoma
Parathyroid hyperplasia
MEN2b features
Medullary Thyroid cancer
Phaeochromocytoma
Neuromas/fibromas + marfanoid features
Inheritance of BRCA mutation
AD, highly penetrant
TP53 gene mutation
Li Fraumeni syndrome
AD inheritance
Li Fraumeni syndrome features
SBLA
-Sarcoma, Breast, leukemia, adrenal gland cancers
Very young onset usually (before 30 yo)
Role of p53 in cancer
Tumor suppressor gene
If DNA is damaged, p53 prevents malignant transformation by delaying cell cycle progression
-Allows cell to initiate DNA repair or can initiate apoptosis
PTEN gene mutation
Cowden Syndrome
AD inheritance
Features of Cowden syndrome
Breast cancer and Skin changes
Papillary thyroid cancer
APC gene mutation
FAP
AD inheritance
MutYH gene mutation
MutYH associated Polyposis
- Phenotypically similar to FAP
- AR inheritance - so may look like de novo FAP
STK11 gene mutation
Peutz Jegher Syndrome
AD inheritance
Features of Peutz Jegher Syndrome
- Hamartomatous polyposis ( low malignant potential)
- Lip, buccal, palm pigmentation
- Risk of intussussception/volvulus
- Increased risk of GI and breast cancer
MMR gene mutations in Lynch Syndrome
MLH1, MSH2, MSH6, PMS2, EPCAM
Amsterdam criteria for Lynch syndrome
3 or more affected relatives w/ CRC
2 or more generations affected
1 or more <50 yo a diagnosis
FAP excluded
How to test for MMR mutations
- MSI testing
- Immunohistochemistry - absent staining seen if defect
- Germ line testing
SDHB gene mutation
paragangliomas and phaeochromocytoma
Neurofibromin 1 gene mutation
neurofibromatoisis type 1
AD inheritance
Neurofibromatoisis type 1 Features
2 or more of: Cafe au lait spots Neurofibroma/plexiform neurofibroma Axillary freckling Lisch modules on irus Optic glioma 1st degree relative w/ NF
Merlin gene mutation
neurofibromatoisis type 2
AD inheritance
Neurofibromatoisis type 2 Features
Bilateral acoustic schwannoma by age 30 usually Meningioma/Neurofibroma/Swannoma/Glioma Polyneuropathy Cataracts Cutaneous tumors/plaques
VHL gene mutation
Von Hippel Lindau Disease
Von Hippel Lindau Disease Features
Clear cell renal cancer
Neurological/retinal haemangioblastoma
Phaeochromocytoma
Compound heterozygote
Different mutations in each pair of a gene
Allelic heterogeneity
The same phenotype can be caused by more than one mutation in a gene (e.g CF)
Locus heterogeneity
The same phenotype can be caused by mutations in more than one gene (e.g. tuberous sclerosis)
Inheritance of Marfans
AD
Inheritance of Tuberous sclerosis
AD
Inheritance of vWD
AD
Inheritance of Noonan Syndrome
AD
Inheritance of Hereditary hemorrhagic telangiectasia
AD
Inheritance of acute intermittent porphyria
AD
Inheritance of Wilsons Disease
AR
Inheritance of Friedrich Ataxia
AR, trinucleotide repeat disorder
Inheritance of Haemochromatosis
AR
Inheritance of Alpha 1 antitrypsin
AR
Inheritance of Phenylketonuria
AR
Equation for incidence of a recessive condition
Incidence = (Carrier Freq^2) x4
Equation for carrier frequency of a recessive condition
Carrier frequency = square root of (incidence/4)
Inheritance of G6PD deficiency
X linked
Inheritance of Fabry Disease
X linked
Inheritance of Chronic granulomatous disease
X linked
Inheritance of Duchenne muscular dystrophy
X linked
Inheritance of Rett syndrome
X linked - Dominant
Inheritance of Fragile X syndrome
Triplet repeat disorder on X chromosome
-Worse when maternally transmitted
Heteroplasmy
Some mitochondria have a mutation and others don’t
When can CVS be performed
11-15 weeks
Needle into placenta
1:500 miscarriage risk
Role for NIPT
Can be done at 10+ weeks
Assesses for aneuploidy, deletion syndromes, gender
-Fragments of placental DNA extracted from maternal blood
CACNA1A gene mutation
Torticollis
Features of tuberous sclerosis
Ungal/periungal fibroma Ash leaf macules Facial angiomas/forehead plaques Shagreen patch Retinal nodular hamartomas Brain - nodules/tubers/astrocytoma - Seizures and ID Renal angiomyolipoma/cysts Cardiac rhabdomyoma LAM - lungs
Tx option in Tuberous sclerosis
mTOR inhibitors
FMR1 gene mutation
Fragile X
-CGG repeat
Features of Friedrich Ataxia
Cerebellum and dorsal root ganglia affected
-Gait and limb ataxia
HOCM
Diabetes
GAA repeat in FXN gene
Abnormal Dystrophin gene
Becker muscular dystrophy
-Deletion/mutation is inframe resulting in a shortened semi functional protein/milder phenotype
Absent Dystrophin gene due to deletion usually
DMD
-Deletion/mutation disrupts the reading frame and therefore no functional protein
DMD features
Delayed motor milestones Broad waddling gait, falls Gower sign - trouble with stairs Calf pseudohypertrophy (muscle replaced with connective tissue/fat) Cardiomyopathy Mild ID Life expectancy 20s
Trisomy 21 features
ID Hypotonia Hearing/Vision Alz disease Congenital heart disease: VSD>endocardial cushion defect>PDA>ASD>TOF Hypothyroid Leukemia OSA
Fragile X features
ID, behavioral proglems Seizures Mitral Valve prolapse PRemature ovarian failure FXTAS
Karyotype
For detection of:
- Aneuploidy
- Balanced translocation (location of gene)
FISH (Fluorescence in situ hybridisation)
Assess for presence of absence of particular DNA sequences on chromosomes
-Balanced rearrangements
CGH microarray
Assess gains/loss of DNA content
- For unbalanced changes
- Can detect: microdeletions/duplications and monosomies and trisomies
NOT for Balanced changes
SNP Array
For copy number neutral variation with genotype abnormalities Allelic imbalance (uniparental disomy, chimerism)
+what CGH microarray does
Sanger Sequencing
For single gene mutations
-Cannot detect deletions/duplications
Single gene sequencing
looks at a particular area of interest and gives precise DNA sequencing of targeted gene
-For changes of a single base within a gene
Southern blot
For Trinucleotide repeat disorders
Looks at DNA
Western Blot
Can be used to look for proteins in trinucleotide repeat disorders like with DMD
Whole genome sequencing
o Detects genes and will inform you if there are sequence abnormalities in the gene, but cannot tell you location of the gene or if genes are missing or added
o Helpful for heterogenous conditions (e.g. epilepsy)
o Not good for triplet repeat disorders and deletions
miRNA
Post transcriptional regulator that binds to complementary sequences in mRNA
siRNA
Small interfering/silencing RNA
Knock down their target RNA
Digenic mutation
Two mutations in 2 different genes that code for different proteins that are often structurally or functionally related that lead to a phenotype/disease
Wolfram Syndrome
DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness)
AR
Gene: WFS1
MELAS
mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes
Mitochondrial disease
Stroke like presentation Seizures Hearing loss Muscle weakness Migraines
CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
NOTCH3 gene mutation on Chromosome 19
CAuse of stroke in young
TIA like Sx and small vessel ischemic strokes